|
|
|
Volumn 7, Issue 1, 2005, Pages
|
|
Circulating tumour necrosis factor-alpha bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELL RECEPTOR;
GLYCOPROTEIN;
INFLIXIMAB;
INTERLEUKIN 6;
MONOCLONAL ANTIBODY;
OSTEOPROTEGERIN;
TNFRSF11B PROTEIN, HUMAN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
ADULT;
AGED;
ARTICLE;
AUTOIMMUNE DISEASE;
BIOASSAY;
BIOSYNTHESIS;
BLOOD;
CELL CULTURE;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
DRUG EFFECT;
FEMALE;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
INDIVIDUALITY;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
METABOLISM;
MIDDLE AGED;
PATHOLOGY;
RHEUMATOID ARTHRITIS;
SYNOVIUM;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, RHEUMATOID;
AUTOIMMUNE DISEASES;
BIOLOGICAL ASSAY;
CELLS, CULTURED;
FEMALE;
GENE EXPRESSION REGULATION;
GLYCOPROTEINS;
HUMANS;
INDIVIDUALITY;
INFUSIONS, INTRAVENOUS;
INTERLEUKIN-6;
MALE;
MIDDLE AGED;
OSTEOPROTEGERIN;
RECEPTORS, CYTOPLASMIC AND NUCLEAR;
RECEPTORS, TUMOR NECROSIS FACTOR;
SYNOVIAL MEMBRANE;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 24144462259
PISSN: None
EISSN: 14786362
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (59)
|
|
References (0)
|
